Clinical significance of jejunoileal involvement of non-Hodgkin's lymphoma detected by double-balloon enteroscopy

被引:2
作者
Ibuka, Takashi [1 ]
Tsurumi, Hisashi [1 ]
Araki, Hiroshi [1 ]
Hara, Takeshi [1 ]
Onogi, Fumito [1 ]
Goto, Naoe [1 ]
Kojima, Yasushi [1 ]
Kanemura, Nobuhiro [1 ]
Shiraki, Makoto [1 ]
Kasahara, Senji [1 ]
Shimizu, Masahito [1 ]
Ogawa, Kengo [1 ]
Ninomiya, Soranobu [1 ]
Nakanishi, Takayuki [1 ]
Kato, Tomohiro [1 ]
Takami, Tsuyoshi [2 ]
Moriwaki, Hisataka [1 ]
机构
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu 5011194, Japan
[2] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu 5011194, Japan
关键词
Double-balloon enteroscopy (DBE); Non-Hodgkin's lymphoma; Jejunoileum; Prognostic factor; INTERNATIONAL PROGNOSTIC INDEX; B-CELL LYMPHOMA; SOLUBLE INTERLEUKIN-2-RECEPTOR SIL-2R; PRIMARY FOLLICULAR LYMPHOMA; UNSPECIFIED PTCL-U; T-CELL; GASTROINTESTINAL-TRACT; CAPSULE ENDOSCOPY; PHASE-II; R-CHOP;
D O I
10.1007/s12185-013-1273-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Jejunoileal involvement of non-Hodgkin's lymphoma (NHL) is an important diagnostic factor in determining optimal treatment strategies. Here, we used double-balloon enteroscopy (DBE) to detect jejunoileal involvement of NHL and studied its clinical significance in a series of patients with NHL. Adults aged between 18 and 85 years with infiltration of the stomach, duodenum, or colon confirmed by gastrointestinal endoscopy or colonoscopy, suspected jejunoileal involvement determined by CT or FDG-PET, or any other gastrointestinal symptoms, were eligible for inclusion in the study. Among 428 patients with histologically confirmed NHL between 2004 and 2011, 83 were eligible for DBE, but 20 patients were excluded due to rejection or poor clinical status. Thus, 63 underwent DBE. The 3-year overall survival rate was significantly lower in patients with (n = 33), than without (n = 30) jejunoileal involvement of NHL confirmed by DBE (49 vs. 92 %, p < 0.005). Four participants developed aspiration pneumonia, but recovered after treatment with antibiotics.
引用
收藏
页码:369 / 381
页数:13
相关论文
共 40 条
  • [1] [Anonymous], 1993, N ENGL J MED, V329, P987
  • [2] PRIMARY LYMPHOMA OF GASTROINTESTINAL-TRACT
    BUSH, RS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 228 (10): : 1291 - 1294
  • [3] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
    Cheson, BD
    Horning, SJ
    Coiffier, B
    Shipp, MA
    Fisher, RI
    Connors, JM
    Lister, TA
    Vose, J
    Grillo-López, A
    Hagenbeek, A
    Cabanillas, F
    Klippensten, D
    Hiddemann, W
    Castellino, R
    Harris, NL
    Armitage, JO
    Carter, W
    Hoppe, R
    Canellos, GP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1244 - 1253
  • [4] CHOTT A, 1992, AM J PATHOL, V141, P1361
  • [5] Primary follicular lymphoma of the gastrointestinal tract:: a study of 25 cases and a literature review
    Damaj, G
    Verkarre, V
    Delmer, A
    Solal-Celigny, P
    Yakoub-Agha, L
    Cellier, C
    Maurschhauser, F
    Bouabdallah, R
    Leblond, V
    Lefrère, F
    Bouscary, D
    Audouin, J
    Coiffier, B
    Varet, B
    Molina, T
    Brousse, N
    Hermine, O
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (04) : 623 - 629
  • [6] FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO
  • [7] 2-#
  • [8] Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
    Gallamini, A
    Stelitano, C
    Calvi, R
    Bellei, M
    Mattei, D
    Vitolo, U
    Morabito, F
    Martelli, M
    Brusamolino, E
    Iannitto, E
    Zaja, F
    Cortelazzo, S
    Rigacci, L
    Devizzi, L
    Todeschini, G
    Santini, G
    Brugiatelli, M
    Federico, M
    [J]. BLOOD, 2004, 103 (07) : 2474 - 2479
  • [9] Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index
    Goto, H
    Tsurumi, H
    Takemura, M
    Ino-Shimomura, Y
    Kasahara, S
    Sawada, M
    Yamada, T
    Hara, T
    Fukuno, K
    Goto, N
    Okuno, M
    Takami, T
    Seishima, M
    Moriwaki, H
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (02) : 73 - 79
  • [10] Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma
    Goto, Naoe
    Tsurumi, Hisashi
    Takemura, Masao
    Hara, Takeshi
    Sawada, Michio
    Kasahara, Senji
    Kanemura, Nobuhiro
    Yamada, Toshiki
    Shimizu, Masahito
    Takahashi, Takeshi
    Tomita, Eiichi
    Seishima, Mitsuru
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (03) : 217 - 225